| Michael J. Vasconcelles |
Michael J. Vasconcelles currently works at Molecular Partners AG, as Independent Non-Executive Director from 2020, Molecular Partners, Inc., as Director, ImmunoGen, Inc., as Chief Medical Officer from 2023, Frazier Management LLC, as Senior Advisor from 2019, American Society of Clinical Oncology, Inc., as Member, and American Society of Hematology, as Member. Dr. Vasconcelles also formerly worked at American Cancer Society New England Division, Inc., as Director, Personalized Medicine Coalition, as Director, Magenta Therapeutics, Inc., as Independent Director, Genzyme Corp., as Group VP & Head-Global Therapeutic Area from 2000 to 2012, Cogent Biosciences, Inc., as Chief Medical Officer from 2015 to 2019, Sanofi SA, as Global Therapeutic Area Head-Transplant & Oncology, Takeda Pharmaceuticals International, Inc., as Senior VP & Head-Oncology Therapy Area Unit from 2012 to 2015, Flatiron Health, Inc., as Chief Medical Officer-Research & Regulatory, and Sanofi Oncology, as Head-Personalized Medicine & Companion Diagnostics. Dr. Vasconcelles received his undergraduate degree from Northwestern University and doctorate degree from Feinberg School of Medicine. |
| Audrey Bergan |
Audrey Bergan is currently the Chief Human Resources Officer & Vice President at ImmunoGen, Inc. She has a graduate degree from Northeastern University and an undergraduate degree from the University of Massachusetts. |
| Stacy A. Coen |
Stacy A. Coen is an Independent Director at FibroBiologics, Inc. and the Chief Business Officer & Senior Vice President at ImmunoGen, Inc. She is also a Member of the Massachusetts Biotechnology Council, the Alliance for Regenerative Medicine, and a Trustee of the Huntington's Disease Society of America. Previously, she held Vice President positions at Genzyme Corp. and Editas Medicine, Inc. Coen received an undergraduate degree from the University of Massachusetts and an MBA from the University of Virginia Darden School of Business. |
| Renee Lentini |
Renee Lentini is currently working as the Chief Accounting Officer at ImmunoGen, Inc. She started this position in 2023. She has a graduate degree from Stonehill College, Inc. |
| Lauren A. White |
Lauren A. White is currently the Chief Financial Officer & Senior Vice President at ImmunoGen, Inc. Prior to this, she was the Treasurer, Chief Financial & Accounting Officer at C4 Therapeutics, Inc. from 2021 to 2023. Before that, she was the VP, Global Head-Business Planning & Analysis at Novartis Institutes for Biomedical Research, Inc. Ms. White holds an MBA from Harvard Business School and an undergraduate degree from Wallace E Carroll School of Management. |
| Rodrigo Ruiz Soto |
Rodrigo Ruiz Soto is currently a Senior Director-Medical at ImmunoGen, Inc. and a Senior Vice President-Clinical Development at Deciphera Pharmaceuticals, Inc. He previously worked as a Medical Director at Sanofi, Inc. He holds a doctorate degree from Universidad Nacional Autónoma de México. |
| Robert Herbst |
Robert Herbst is currently working as the Vice President-Technical Operations at ImmunoGen, Inc. He holds a doctorate degree from the University of Massachusetts. |
| Todd Lewis Talarico |
Todd Lewis Talarico is currently the Chief Commercial Officer & VP-Market Access at ImmunoGen, Inc. He previously worked as the Director-Product Development at Apex Bioscience, Inc., Vice President-Process Development at Medicago, Inc., and Principal at AlphaVax, Inc. Talarico holds a doctorate degree from North Carolina State University and an undergraduate degree from The Pennsylvania State University. |
| Theresa G. Wingrove |
Theresa G. Wingrove is currently the Senior Vice President-Regulatory Affairs & Quality at ImmunoGen, Inc. She previously worked as the Senior Director-Clinical & Regulatory Affairs at MediSpectra, Inc. from 2000 to 2010. She also held the position of Vice President-Clinical & Regulatory Affairs at Histogenics Corp. from 2006 to 2011. Dr. Wingrove has a doctorate degree from the University of Rochester and an undergraduate degree from Brown University. |
| Isabel Kalofonos |
Isabel Kalofonos is currently the Chief Commercial Officer & Senior Vice President at ImmunoGen, Inc. Prior to this, she worked as the Head-Prescription Business Unit at Galderma Holding SA. She holds an MBA from Babson College and an undergraduate degree from Pontificia Universidad Javeriana. |
| Daniel S. Char |
Daniel S. Char is currently the Secretary, Chief Legal Officer & Senior VP at ImmunoGen, Inc. He previously worked as an Associate General Counsel at Biogen, Inc. from 1995 to 2006, as a Senior Associate General Counsel at Idenix Pharmaceuticals LLC from 2006 to 2007, as the Secretary, Vice President & General Counsel at Targanta Therapeutics Corp. from 2008 to 2009, and as the Associate General Counsel-Commercial at Smith + Nephew, Inc. from 2009 to 2018. He also briefly served as the General Counsel at Evelo Biosciences, Inc. in 2018. Mr. Char received his undergraduate degree from Tufts University in 1983 and his graduate degree from Harvard Law School in 1986. |
